© Florida Institue for Clinical Research | Privacy Policy
Website by 
[realtime-embed site="ficr" script="yes"]
Cardiovascular Health (Lepodisiran)
The purpose of this study is to investigate the effect of Lepodisiran on the reduction of major adverse cardiovascular events in adults with elevated Lipoprotein(a).
COPD (HFO Propellant)
This study will investigate the effect on lung function of an approved COPD treatment (BGF, with HFA propellant) compared to BGF formulated with a new propellant (HFO).
COPD (NEXThaler)
The purpose of the study is to investigate whether a new investigational add-on medication (NEXThaler) will reduce airway inflammation and improve COPD symptoms in people on maintenance triple therapy.
COPD (Solrikitug)
Participants dealing with the challenges of Chronic Obstructive Pulmonary Disease (COPD) have a potential new option in the form of a medication called Solrikitug.
COPD (THARROS)
A Study Evaluating the Efficacy of Breztri/Trixeo on Cardiopulmonary Outcomesin patients with Chronic Obstructive Pulmonary Disease.
COPD (TRITON)
The primary purpose of the Triton study is to see how safe the study drug is and how well it works to control the symptoms of COPD.
High Triglycerides (ARO-APOC3)
The purpose of this study is to evaluate the safety and efficacy of plozasiran injection (ARO-APOC3) to reduce levels in adult participants with hypertriglyceridemia (HTG).
High Triglycerides (ARO-APOC3 for Severe Hypertriglyceridemia)
The purpose of this study is to evaluate the safety and efficacy of plozasiran injection (ARO-APOC3) to reduce levels in adult participants with severe hypertriglyceridemia (SHTG).